Recombinant MLANA anticorps
-
- Antigène Voir toutes MLANA Anticorps
- MLANA (Melan A (MLANA))
- Type d'anticorp
- Recombinant Antibody
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp MLANA est non-conjugé
-
Application
- Immunohistochemistry (IHC)
- Immunogène
- Recombinant full-length hMART-1 protein
- Clone
- MSVA-901M-
- Isotype
- IgG
- Top Product
- Discover our top product MLANA Anticorps primaire
-
-
- Indications d'application
- IHC 1:50-1:100
- Commentaires
-
Positive Control: Skin: Virtually all melanocytes should show a strong Melan A+ immunostaining including a weak to moderate staining in melanocytic dendrites. Adrenal gland: An at least moderate Melan A+ immunostaining should be seen in adrenocortical cells.
Negative Control: Kidney: Melan A immunostaining should be absent in all cells. Adrenal gland: Melan A+ immunostaining should be absent in all medullary cells.
- Protocole
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:75 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Stock
- 4 °C,-20 °C,-80 °C
- Stockage commentaire
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
- Antigène
- MLANA (Melan A (MLANA))
- Autre désignation
- Melan A (MLANA Produits)
- Synonymes
- anticorps A930034P04Rik, anticorps Mart1, anticorps MART-1, anticorps MART1, anticorps melan-A, anticorps Mlana, anticorps MLANA
- Sujet
- Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA,Melan A antibody validated for immunohistochemistry on 76 different Normal Tissues
- UniProt
- Q16655
-